Related Experiment Video
Updated: Aug 1, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Stroke recurrence and its prevention in patients with patent foramen ovale
J U Harrer1, T Wessels, A Franke
1Department of Neurology, Aachen University Hospital, Aachen, Germany.
Insights
Medical or invasive treatments for stroke in patent foramen ovale (PFO) patients show low recurrence. Previous ischemic events and larger shunts are key risk factors for recurrent strokes.
Area of Science:
- Neurology
- Cardiology
- Vascular Medicine
Background:
- Patent foramen ovale (PFO) is a suspected cause of cryptogenic stroke.
- Optimal treatment strategies to prevent recurrent ischemic events remain unclear.
- The role of concomitant risk factors in stroke recurrence requires further elucidation.
Purpose of the Study:
- To compare the effectiveness of medical versus invasive (catheter or surgical) treatments for PFO-related stroke prevention.
- To identify risk factors associated with recurrent ischemic events in patients with PFO.
Main Methods:
- A prospective observational study followed 124 patients with cryptogenic cerebral ischemia and PFO for a mean of 52 months.
- Patients were treated medically (n=83), with transcatheter closure (n=34), or surgical closure (n=7).
- Recurrent ischemic events and associated risk factors were analyzed.
Main Results:
- Annual stroke recurrence rates were low and comparable between medical and catheter-treated groups (2.9% vs. 2.1%).
- Patients with recurrent strokes had significantly larger shunts (OR=5.0) and a history of previous ischemic events (OR=4.4).
- Pulmonary embolism and case fatality rates were higher in patients experiencing stroke recurrence.
Conclusions:
- The absolute risk of recurrent cerebrovascular events is low with medical or catheter interventional therapy for PFO.
- Previous ischemic events and shunt size are significant risk factors for recurrence.
- Randomized controlled trials are recommended to definitively establish optimal treatment strategies.
Background:
It is unclear whether medical or invasive (surgical or catheter interventional) treatment is preferable to prevent recurrence of cerebral ischemia in patients with patent foramen ovale (PFO) as the suspected cause of stroke and what the role of concomitant risk factors is in stroke recurrence.
Methods:
Over a period of ten years, 124 patients (mean age 51 +/- 15 years) with cryptogenic cerebral ischemia and PFO were included into the study and prospectively followed over a mean of 52 +/- 32 months. Of these, 83 were treated medically, 34 underwent transcatheter closure, and seven had surgical closure of the foramen. Of the medically treated patients, 11 stopped medication during follow-up. Recurrent ischemic events and risk factors for recurrence were analyzed.
Results:
Annual stroke recurrence rates were generally low and comparable in catheter and medically treated patients, and in patients who had stopped medication (2.9%/2.1%2.2%/year). Patients suffering from recurrence after transcatheter closure (n = 2) both had residual shunts. No stroke recurrence was observed in the few surgically treated patients. An atrial septal aneurysm was not a predictor of recurrent or multiple strokes (p > 0.05, OR = 0.31, and OR = 0.74). Large shunts and a history of previous ischemic events were considerably more frequent in patients with recurrent strokes (p < 0.05, OR = 5.0, and OR = 4.4). Pulmonary embolism and case fatality rates were significantly higher in patients with stroke recurrence (p < 0.001, and p < 0.01).
Conclusions:
The absolute risk of recurrent cerebrovascular events in patients with PFO receiving medical or catheter interventional therapy is low. The small group of untreated patients had a comparably low rate of stroke recurrences. Previous ischemic events and shunt size were risk factors in this observational study. Given conflicting findings across multiple studies, enrollment into a randomized controlled trial would be the optimal choice.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Stenosis IV: Nursing Management
Coronary Artery Disease IV: Preventive Measures
Venous Thrombosis III: Interprofessional Care
Hemorrhagic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction

